Abstract
The utility of the tert- butylsulfonyl
group (Bus) for the temporary protection of amino acids and peptides
is reported. Compatibility and orthogonality in the presence of
other N- and O-protecting groups were studied.
Key words
tert- butylsulfonyl group - amino-group
protection - amino acids - orthogonal N-protection
References and Notes
<A NAME="RS08309ST-1A">1a </A>
Llobet AI.
Alvarez M.
Albericio F.
Chem. Rev.
2009,
109:
2455
<A NAME="RS08309ST-1B">1b </A>
Ribiere P.
Declerck V.
Martinez J.
Lamaty F.
Chem. Rev.
2006,
106:
2249
See also:
<A NAME="RS08309ST-1C">1c </A>
Kocienski PJ.
Protecting Groups
Thieme;
New
York:
2000.
<A NAME="RS08309ST-1D">1d </A>
Greene TW.
Wuts PGM.
Protecting Groups in Organic Synthesis
J.
Wiley and Sons;
New York:
1999.
<A NAME="RS08309ST-2">2 </A>
Fukuyama T.
Jow CK.
Cheung M.
Tetrahedron
Lett.
1995,
36:
6373
<A NAME="RS08309ST-3">3 </A>
Sun P.
Weinreb SM.
Shang M.
J.
Org. Chem.
1997,
62:
8604
<A NAME="RS08309ST-4">4 </A>
Gontcharov AV.
Liu H.
Sharpless KB.
Org.
Lett.
1999,
1:
783
<A NAME="RS08309ST-5A">5a </A>
Borg G.
Chino M.
Ellman JA.
Tetrahedron Lett.
2001,
42:
1433
<A NAME="RS08309ST-5B">5b </A>
Beenan MA.
Weix DJ.
Ellman
JA.
J. Am. Chem. Soc.
2006,
128:
6304
<A NAME="RS08309ST-6A">6a </A>
Schleusner M.
Gais H.-J.
Koep S.
Raabe G.
J.
Am. Chem. Soc.
200,
124:
7789
<A NAME="RS08309ST-6B">6b </A>
Gunter M.
Gais H.-J.
J. Org. Chem.
2003,
68:
8037
<A NAME="RS08309ST-6C">6c </A>
Tiwari SK.
Schneider A.
Koep S.
Gais H.-J.
Tetrahedron
Lett.
2004,
45:
8343
<A NAME="RS08309ST-7A">7a </A>
Hodgson DM.
Humphreys PG.
Ward JG.
Org. Lett.
2005,
7:
1153
See also:
<A NAME="RS08309ST-7B">7b </A>
Coote SC.
Moore SP.
O’Brien P.
Whitwood AC.
Gilday J.
J. Org. Chem.
2008,
73:
7852
<A NAME="RS08309ST-7C">7c </A>
Hodgson DM.
Miles TJ.
Witherington J.
Synlett
2002,
310
<A NAME="RS08309ST-7D">7d </A>
Morton D.
Pearson D.
Field RA.
Stockman RA.
Org. Lett.
2004,
6:
2377
<A NAME="RS08309ST-8">8 </A>
Hanessian S.
Del Valle JR.
Xue Y.
Blomberg N.
J. Am. Chem.
Soc.
2006,
128:
10491
<A NAME="RS08309ST-9">9 </A>
General Procedure
for the Formation of
tert
-Butyl-sulfonamides
A solution
of l -phenylanine ethyl ester hydrochloride
(1a , 58 mg, 0.25 mmol) in CH2 Cl2 (3
mL) was cooled to 0 ˚C and treated with Et3 N
(0.35 mL, 2.5 mmol), followed by dropwise addition of tert -butylsulfinyl chloride (62 µL,
0.5 mmol) in CH2 Cl2 (1 mL). The reaction mixture
was stirred at 0 ˚C until TLC showed consumption of the
starting material (1 h). Upon completion, sat. aq NaHCO3 (5
mL) were added, and the layers separated (note: acidic washes should
be avoided as tert -butylsulfinamides 2a are known to be unstable at low pH).
The organic layer was then dried over Na2 SO4 and
concentrated under reduced pressure. Flash column chromatography
(EtOAc-hexane, 3:2) afforded pure sulfinamide 2a which was directly taken up in CH2 Cl2 (5 mL),
and treated with MCPBA (58 mg, 0.34 mmol) at 0 ˚C. After
the oxidation was complete by TLC (at r.t. for 1 h), the mixture
was diluted with a mixture of sat. aq NaHCO3 (5 mL) and
sat. aq Na2 SO3 (5 mL). The aqueous layer was extracted
with CH2 Cl2 (2 × 10
mL). The organic extracts were combined, dried over Na2 SO4 ,
and concentrated under reduced pressure. The crude residue was purified
by flash column chromatography (EtOAc-hexane, 1:1) to afford tert -butylsulfonyl-l -phenylalanine
ethyl ester (3a , 66 mg, 84% over
2 steps) as a colorless solid.
<A NAME="RS08309ST-10">10 </A>
General Procedure
for the Cleavage of
tert
-Butylsulfonamides
To a solution
of anisole (0.22 mL, 2.0 mmol) and tert -butylsulfonyl-l -alanine methyl ester (3d ,
45 mg, 0.2 mmol) in CH2 Cl2 (3 mL) was slowly
added TfOH (0.2 N in CH2 Cl2 , 3 mL) at 0 ˚C.
The solution was stirred at 0 ˚C for 2 h, then warmed to
4 ˚C for 10 h (TLC monitoring, EtOAc-hexane, 2:3),
then H2 O (6 mL) was added. The aqueous layer was neutralized
with DOWEX Monosphere 550A (OH- form) anion-exchange
resin at 0 ˚C until pH 8.5, then MeOH (6 mL) was
added, and the resin was filtered. The filtrate was combined and
acidified with aq 1 M HCl (3 mL). The aqueous layer was frozen and
lyophilized to afford l -alanine methyl
ester hydrochloride salt(1d ) (24 mg, 85%),
as a colorless oil.
<A NAME="RS08309ST-11">11 </A>
Enantiomeric and diastereomeric purities
were determined by HPLC and ¹ H/¹9 F
NMR spectra of Mosher amides. For example: Mosher amides: phenylalanine
(de >99.9%) and alanine (de >99.9%)
Column: AD-RH 150 × 4.6 mm; dipeptides: 21 (de >99.9%), 22 (de >99.9%), 29 (de >99.9%), and 30 (de = 99.86%),
column: AS-RH 150 × 4.6 mm; 23 (de = 95.66%)
and 31 (de = 96.24%),
column: OJ-R 150 × 4.6 mm; 23 (de = 95.50%)
and 31 (de = 92.22%), column:
C-18 250 × 4.6 mm.